Peripheral Vascular Disease III: Management

Peripheral Vascular Disease III: Management

c36-fig-5001

Conservative (Non-surgical) Management


All patients with PVD should be managed with conservative management and BMT, including those who have also undergone an intervention (endovascular and/or surgery). As a guide, for those undergoing conservative management alone, about a third of patients will improve, a third will stay the same and about a third will suffer symptomatic deterioration over a 6-month period.


Lifestyle Adjustment



  • Smoking cessation (nicotine replacement and counselling enhances compliance!).
  • Hypertension management (<140/90) and lipid optimisation.
  • Diabetic control and treatment of renal failure.
  • Exercise (supervised classes enhances compliance!).
  • Weight loss and healthy diet.

Best Medical Therapy



  • Antiplatelet agent (APA).
  • Statin therapy (regardless of baseline lipid profile).
  • BP and glucose control.
  • Low dose ACEi (regardless of BP).
  • Cilostazol (+/− other vasodilators).

Revascularisation


This includes angiointervention or open surgery. The decision to proceed will depend on numerous factors:



  • General health versus risks of procedure (30% mortality <5 years!).
  • Vessel suitability (length and number of lesions).
  • Is there a suitable access site (angiointervention)?
  • Is there a suitable distal target vessel for anastomosis (surgery)?
  • Is amputation a better option (poor health/non-reconstructable)?

Indications for Intervention


Absolute Indications



  • Critical ischaemia:

    • Ischaemic rest pain.
    • Tissue loss/gangrene.

Stay updated, free articles. Join our Telegram channel

Jul 1, 2016 | Posted by in CARDIOLOGY | Comments Off on Peripheral Vascular Disease III: Management

Full access? Get Clinical Tree

Get Clinical Tree app for offline access